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Summary
Objective. The aim of this study was to evaluate the effectiveness of a com-
puter-assisted cognitive remediation program (CACR) (through the use of the 
Cogpack software) on cognitive outcomes, symptomatology, and real-world 
functioning compared to a control active group following 24 weeks of treatment 
in a sample of outpatients with stable schizophrenia.
Materials and methods. Forty-four outpatients took part in the study: twenty-
three of them were allocated to CACR and twenty-one to the control active 
group. First, we calculated chi-square tests for categorical variables and the 
univariate analysis of variance (one-way ANOVA) analyses of variance for con-
tinuous variables. Second, an ANOVA for repeated measures was performed 
for clinical and psychosocial variables. 
Results. A significant improvement over trial duration (within-group effect) was 
observed for both treatments in positive (PANSS-P), negative (PANSS-N), gen-
eral symptoms (PANSS-G), and verbal learning (HVLT-R). CACR was found 
superior to the control active group (between group effect) in improving specific 
cognitive domains: processing speed (TMT, BACS, fluency); verbal learning 
(HVLT-R); reasoning and problem solving (NAB); visual learning (BVMT-R); at-
tention/vigilance (CPT-IP); social cognition (MSCEIT-ME); social acceptability 
(SLOF social acceptability). No differences were found between groups for the 
other clinical outcomes’ measures.
Conclusions. Our data suggest that the use of CACR is important to imple-
ment not only specific cognitive functions, but also functioning in daily life and 
social cognition in patients with stable schizophrenia. 
Introduction
Cognitive deficits have been considered a nuclear feature of schizophrenia: 
they are already present at the onset of the disorder, but also in the prodromal 
phase and tend to be stable over time. The impairment of cognitive perfor-
mance is, on average, two standard deviations below healthy controls 1 and 
only 15-30% of patients are not deficient in neuropsychological tests, despite 
having a reduced cognitive functioning based on the premorbid level and the 
level of parental education 2. Cognitive deficits are the most important deter-
minant in the impairment of the daily functioning of patients with schizophre-
nia: they explain, globally, from 20 to 60% of the variance of functioning, with 
differences ascribable to the heterogeneity of the samples and the evalua-
tion tools adopted 3 4. An impairment in cognitive domains such as processing 
speed, attention, episodic memory, working memory and executive functions 
is strongly associated with poorer psychosocial functioning, including quality of 
social relationships, role functioning, self-care skills, and independent living 5 6. 
C. Montemagni et al.
2 - EbPsyC
Moreover, cognitive impairment attenuates response  to 
psychiatric rehabilitation, such as supported employment 
and social skills training 7.
To treat cognitive deficits and, later, act on the functioning 
of patients with schizophrenia, cognitive remediation (CR) 
methods have been developed and evaluated 8. The most 
common of these methods include strategy coaching to 
improve performance on cognitive exercises, teaching 
cognitive compensatory (or self-management) strategies 
to reduce the effects of impaired cognitive functioning in 
everyday life, and drill-and-practice of cognitive exercis-
es  9. The goal of strategic training is to improve perfor-
mance by explicitly learning and applying cognitive strate-
gies, such as mnemonics 10.
On the other hand, the principle of drill and practice train-
ing has been adopted in the design of computer-assisted 
cognitive remediation CR programs (CACR) for patients 
with schizophrenia-spectrum disorders (e.g. CogPack 
and CogRehab). These computer programs are flexible 
and have several advantages over the pen and pencil 
programs, such as the enhancement of motivation due to 
the sensory variety that these exercises present 11 12, and 
the possibility of providing immediate feedback 13. Other 
important features of CACR are its presentation of cus-
tom-tailored and adaptive tasks that can take into account 
the patient’s deficits and their evolution over the course of 
therapy (specific sets of exercises can be individualized 
for the individual cognitive functions in which the patient is 
deficient, it is possible to modulate the difficulty based on 
individual answers) 14, standardization of instructions, and 
the possibility to perform the training with only little help 
from therapist, thereby containing costs 15.
However, evidence for the efficacy of such programs in 
improving (cognitive) functioning remains unclear.
Three meta-analyses including both drill and practice and 
strategic training and coaching showed that CR in general 
was effective in a broader sense on cognitive functioning 
in patients with schizophrenia-spectrum disorders  10 16 17. 
More specifically, Wykes et al. (2011) showed that both 
drill and practice and strategic training improved cogni-
tive outcomes; McGurk et al. (2007) found a larger effect 
on verbal learning and memory for drill and practice train-
ing alone, rather than combined with strategic training. 
Lastly, Grynszpan et al. (2011) performed a meta-analysis 
on 16 randomized controlled trials evaluating CACR and 
showed positive results on general cognition, with small 
effect sizes on verbal memory, working memory, atten-
tion/vigilance and speed of processing and a significant 
medium effect size for social cognition. Interestingly, cog-
nitive domains that were specifically targeted by the inter-
ventions did not yield higher effects than those that were 
not, suggesting a “non-specific” effect of CACR. 
A more recent metanalysis 11 including 24 studies specifi-
cally focused on computerized drill and practice programs 
showed that computerized cognitive training had a supe-
rior effect on attention and working memory, as well as 
on positive and depressive symptoms, when compared to 
a control condition. Furthermore, small to moderate, but 
only marginally significant effects were found for process-
ing speed, verbal fluency, and verbal and visual learning 
and memory. No convincing evidence for improvement in 
general cognition, reasoning and problem solving, social 
cognition, and functional outcomes has emerged. More-
over, while longer illness duration was related to larger 
effect sizes for attention, shorter treatment duration was 
related to higher effect sizes on working memory and vi-
sual and verbal learning and memory. Thus, the dubious 
effects on social cognition and functional outcomes ques-
tions the generalization of cognitive improvement to other 
domains.
Therefore, in light of these considerations and the growing 
interest in CR programs, the objective of the present study 
was to evaluate, in a sample of outpatients with schizo-
phrenia, the effectiveness of a CR program (through the 
use of the Cogpack software) in addition to standard ther-
apy on cognitive outcomes compared to a control active 
group and to highlight a possible effect on symptomatol-
ogy and real-world functioning.
Materials and methods 
Subjects
The present study was conducted at the Dipartimento di 
Neuroscienze “Rita Levi Montalcini”, Università degli Studi 
di Torino, Dipartimento di Neuroscienze e Salute Mentale, 
Struttura Semplice Dipartimentale Coordinamento As-
sistenziale Psichiatrico Ospedale-Territorio, AOU Città 
della Salute e della Scienza - Presidio Molinette, Torino, 
Italy and the Dipartimento Interaziendale di Salute Men-
tale ASL TO3 & AOU San Luigi Gonzaga, Italy, in the peri-
od between October 2017 e March 2019. Patients, initially 
evaluated by a psychiatrist, if they met the DSM-5 criteria 
for diagnosis of schizophrenia, were subsequently visited 
by our research group. The patients examined were aged 
between 18 and 65 years. The study was conducted on a 
sample of outpatients with diagnosis of schizophrenia in 
stable phase of illness. 
The exclusion criteria were the following: a) co-presence 
of a diagnosis of intellectual disability and learning dis-
abilities; b) hospitalization in psychiatric facilities in the six 
months prior to evaluation, and significant change of an-
tipsychotic medications during the previous three months 
(according to clinical judgement). 
Participants were recruited through referrals from attend-
ing psychiatrists or clinical staff at the psychiatric medical 
facilities where the study was conducted. 
Written informed consent was obtained from all subjects 
after a complete description of the study. All patients were 
submitted to standard care provided in community mental 
health centers in Italy (pharmacological treatment, clinical 
monitoring at least on a monthly basis, home care when 
required). 
Interventions
All patients recruited in the trial were allocated to one of 
the two interventions, computer-assisted CACR (Cog-
pack) and control active group.
In this trial, patients were considered completers if they 
attended at least 80% of the planned sessions.
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Control active group
This condition was designed to control for nonspecific 
treatment effects. It specified an equal number of one-on-
one computer sessions with the same trainers who con-
ducted the CACR sessions, using the same schedule as 
the treatment arm: two-hour biweekly sessions. It offered 
supportive trainer interactions and matched experience 
with computers and varied computer activities. Control 
activities were selected for game-like properties and low 
cognitive demand. Participants in this condition did not re-
ceive problem-solving training or guided practice on the 
exercises used in the remediation condition. The control 
sessions were also videotaped and reviewed in supervi-
sion meetings.
Cognitive remediation group
The CACR group received 48 sessions computerized 
rehabilitation using Cogpack software, performed twice 
weekly, for a total of 24 weeks of treatment, in addition to 
standard therapy.
Cogpack is a computer-assisted cognitive remedy that re-
quires the use of different abilities, including: visuomotor 
speed, understanding, concentration, alertness, language, 
memory and other cognitive functions. The exercises are 
grouped according to the cognitive domains that are tested: 
visuomotor skills, vigilance, language, memory, logic and 
calculations, daily skills, culture and special element ori-
entation. The Cogpack software includes 64 different tests 
that can be composed to generate 540 different rehabilita-
tion programs, so that it is possible to personalize the reha-
bilitation adapting it to the neuropsychological deficit found 
in the patient. Based on the results obtained by the patients 
in the previous tests, the exercises can be modulated in a 
programmed way or self-modulated by the software itself 
so that it can always improve individual performance. The 
variability of the exercises in the same category also makes 
it possible to rehabilitate the same neurocognitive function 
by using new tasks as soon as the patient manages to 
solve all the levels of the same exercise. The therapist has 
a fundamental role, because he allows learning without er-
rors (as the patient with schizophrenia shows poor learning 
and trial skills); he must also set the initial level of the task 
to allow greater chances of success and finally he must not 
miss a continuous positive reinforcement that helps the pa-
tient to understand the reasons of possible failures and to 
improve himself. We also conducted a weekly group ses-
sion designed to promote the transfer of improved cognitive 
functioning to real-world situations. The trained therapists 
also provided participants teaching compensation strategy 
or prompting additional practice if needed.
Additionally, at least one therapist at each site had to take 
1-day training course to learn the CACR program before 
the study was started. Therapists involved in the interven-
tion were psychologists, and technicians of psychiatric 
rehabilitation who were familiar with psychiatric rehabilita-
tion for schizophrenia, and supervised during the study 
period by members of the research team who had sev-
eral years of experience with CR. Internet conferences 
between members of the research team were also held 
during the study period. Using computer software and the 
manual also minimizes the disparity of efficacy in cogni-
tive remediation.
In the CACR training, participants were directed to prac-
tice a wide range of cognitive domains in both the early 
and later phases of remediation, and each participant 
could choose either preferable tasks or unskilled tasks to 
enhance their interests or self-efficacy in the later phase. 
In the groups, participants talked about their weak tasks, 
and discussed with each other strategies to complete 
tasks using some cognitive functioning in the early phase. 
In the middle and later phases, they also discussed so-
cial goals and how to transfer gained cognitive skills to 
achieve their goals.
The trial was carried out in accordance with the Declara-
tion of Helsinki of 1995 (as revised in Edinburgh in 2000) 
and was approved by the Local Ethical Committee.
Patients were evaluated using a semi-structured interview 
to assess demographic and clinical features. Data were 
collected to determine age, gender, years of education, 
status of employment, marriage or an equivalent long-
term relationship, length of illness, number of hospitaliza-
tions and antipsychotic treatment. 
Psychiatric assessment
All subjects were evaluated at baseline (T0) and after six 
months (T1) with the following evaluation instruments: the 
Positive and Negative Syndrome Scale (PANSS); The 
Calgary Depression Scale for Schizophrenia (CDSS); 
the MATRICS Consensus Cognitive Battery (MCCB); the 
Specific Levels of Functioning Scale (SLOF).
Current levels of psychopathological symptoms were as-
sessed using the PANSS, which includes positive symp-
toms (PANSS-P), negative symptoms (PANSS-N), and 
general psychopathology (PANSS-G) subscales. The 
CDSS was used to measure depressive symptoms 18.
Neurocognition was measured according to the 7 cogni-
tive domains of the MCCB  19-21, derived from scores on 
10  cognitive measures: speed of processing (Trail Mak-
ing Test Part A; Brief Assessment of Cognition in Schizo-
phrenia: Symbol Coding; Category Fluency Test: animal 
naming), attention/vigilance (Continuous Performance 
Test: Identical Pairs), working memory (Wechsler Memory 
Scale; spatial span subset; Letter Number Span Test), 
verbal learning (refers to immediate verbal memory, Hop-
kins Verbal Learning Test (HVLT)-Revised, immediate re-
call), visual learning (refers to immediate visual memory, 
Brief Visuospatial Memory Test-Revised), reasoning and 
problem solving (Neuropsychological Assessment Bat-
tery (NAB), mazes subtest).
The assessment of SC included a test contained in the 
MCCB: the Mayer Salovey Caruso Emotional Intelligence 
Test (MSCEIT)  22, managing emotion section, which ex-
amines the regulation of emotions in oneself and in one’s 
relationships with others by presenting vignettes of vari-
ous situations, along with ways to cope with the emotions 
depicted in these vignettes. It was integrated by the Fa-
cial Emotion Identification Test (FEIT) 23, which examines 
emotion perception, and The Awareness of Social Infer-
ence Test (TASIT)  24, which is a TOM test consisting of 
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7 scales (positive emotions, negative emotions, sincere, 
simple sarcasm, paradoxical sarcasm, sarcasm enriched, 
lie), organized into three sections: Emotion Recognition; 
Social Inference (minimal); Social Inference (enriched). 
The manual of the TASIT was translated into Italian by a 
psychiatrist of the Department of Psychiatry of the Uni-
versity of Campania “Luigi Vanvitelli”, Naples, who gained 
experience in the use of the English version of the instru-
ment during his stage at the Department of Psychiatry and 
Biobehavioral Sciences at University of California, Los 
Angeles (UCLA), as part of his PhD Course. The video-
taped vignettes of the TASIT were dubbed in Italian at the 
Fono Roma Studios (www.fonoroma.com), a prestigious 
society in the field of film industry. As to the FEIT, the ad-
aptation of the Italian version required the translations of 
the six emotions reported on the screen above the stimuli.
Real-life functioning was measured using the SLOF 25-27. 
The original SLOF is a 43-item self- or informant-rated 
scale of a person’s behavior and functioning which was 
abbreviated to assess the following domains: Interper-
sonal Functioning (e.g. initiating, accepting and maintain-
ing social contacts; effectively communicating), Indepen-
dent participation in Everyday Activities (shopping, using 
telephone, paying bills, use of leisure time, use of pub-
lic transportation), and Vocational Functioning (e.g. em-
ployable skills, level of supervision required to complete 
tasks, ability to stay on task, completes tasks, punctual-
ity). The SLOF consists of 43 items. Each of the questions 
is rated on a 5-point Likert scale, indicating the level of 
assistance the participant needs to perform the task, with 
higher score indicating better functioning. Scores on the 
instrument range from 43 to 215. The SLOF differs from 
the other outcome measures in emphasizing patient’s cur-
rent functioning and observable behavior, as opposed to 
inferred mental or emotional states, and focuses on a per-
son’s skills, assets, and abilities rather than deficits that 
once served as the central paradigm guiding assessment 
and intervention for persons with disabilities. Moreover, 
the SLOF does not include items relevant to psychiatric 
symptomatology or NC dysfunctions 25 27. 
Statistical analysis 
Statistical analyses were performed using the Software 
System Statistical Package for the Social Sciences, 
SPSS, version 25 for Windows (SPSS, Chicago, IL, USA).
Data are expressed as average and standard deviation or 
percentages. 
Analyses were planned in two stages. In stage 1, we per-
formed chi-square tests for categorical variables and the 
univariate analysis of variance (One-way ANOVA) analy-
ses of variance for continuous variables, in order to ex-
amine whether the two groups differed in baseline socio-
demographic and clinical variables.
In stage  2, an ANOVA for repeated measures was per-
formed for clinical and psychosocial variables. The be-
tween-subject factor was the group (CACR/control active 
group), and the within-subject factor was time (T0; T1). 
Effects of time (longitudinal dimension), group (cross-sec-
tional dimension), and time by group (interaction effect) 
were examined. 
Results 
Forty-four outpatients meeting DSM-V criteria for schizo-
phrenia took part in the study.
Twenty-three of these patients were allocated to CACR and 
twenty-one of them to the control active group. Five pa-
tients dropped-out from the CACR group and six from the 
control active group. Therefore, the final sample included 
18 patients in the CACR group and 15 subjects in the con-
trol active group. Statistical analyses were performed on 
patients who completed the sessions of treatment. There 
were no significant differences with one-way ANOVA and 
chi-square test in socio-demographic, cognitive, and clini-
cal characteristics between the two treatment groups, ex-
cept for age, as patients in the active control group were 
older than those in the CR group. In addition, the severity 
of symptoms at baseline measured with the PANSS was 
not significantly different between groups.
Socio-demographic, cognitive, and clinical variables of 
the two treatment groups at baseline are shown in Table I.
Results of the evaluation scales for the two treatment 
groups at T0 and at T1 are displayed in Table II. A signifi-
cant improvement over trial duration (within-group effect) 
was observed for both treatments in positive (PANSS-P), 
negative (PANSS-N), general symptoms (PANSS-G) and 
verbal learning (HVLT-R).
CACR was found superior to the control active group (be-
tween group effect) in improving specific cognitive do-
mains: processing speed (TMT, BACS, Fluency); verbal 
learning (HVLT-R); reasoning and problem solving (NAB); 
visual learning (BVMT-R); attention/vigilance (CPT-IP); 
social cognition (MSCEIT-ME), social acceptability (SLOF 
Social Acceptability).
No differences were found between groups for the other 
clinical outcomes’ measures.
Discussion 
This study was aimed to assess the effectiveness of 
CACR versus a control active group on specific clinical 
and functional domains in a sample of outpatients with 
schizophrenia spectrum disorders. The CACR group was 
contrasted with an active experimental condition that 
controlled for nonspecific elements of the remediation 
training, including supportive therapist interactions and 
exposure to interesting computer activities. Outcomes 
were assessed at three levels: proximally, on the remedi-
ation training exercises; intermediately, on neuropsycho-
logical measures not involved in the training; and more 
distally, on proxy measures of everyday functioning. The 
two groups taking part in the study were well matched 
at baseline assessment on demographic (except for 
age) and clinical confounding variables (i.e. depression) 
that could negatively impact the outcome measures and 
made biased the study results. 
We found that CACR and active control group can be 
considered both effective treatments for patients suffer-
ing from schizophrenia spectrum disorders. In fact, both 
interventions showed a significant and similar efficacy in 
improving symptomatology. 
Nevertheless, some specific differences between the two 
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groups were observed. In particular, the CACR therapy 
group presented improvements, after six months of treat-
ment, in specific cognitive domains (processing speed, 
verbal learning, reasoning and problem solving, visual 
learning, attention/vigilance), social cognition, and social 
acceptability, whereas the active control group did not. 
Working memory remained unaffected by both treatments. 
Lastly, while verbal learning improved in both groups over 
assessment occasions, a significant time×group inter-
action was evident, suggesting an advantage for CACR 
training in this specific neurocognitive domain.
Several studies have been performed to examine the effec-
tiveness of CACR therapy in addition to usual treatments in 
patients with schizophrenia and they obtained discordant re-
sults. The lack of consistent findings across studies is not 
surprising considering the methodological limitations of the 
studies published thus far 8. Most of them have had modest 
sample sizes of under 60 participants receiving a particular 
type of cognitive remediation 28-32, and two studies combined 
participants receiving different types of CR 31 33. Three stud-
ies evaluated CR interventions with as few as one 32 to ten 
sessions 28 29. Moreover, CR studies are conducted on inpa-
tients 34-36 and outpatients 37-40. Although evidence indicates 
that the patient status is not of importance, it may, however, 
be essential for a massed treatment schedule as adherence 
is more difficult to ascertain in outpatients 14. Lastly, CACR 
have the potential to be performed independently by the pa-
tient. Many papers did not provide sufficient information on 
this topic and it is not possible to assess the effect of the 
amount of therapist involvement on training efficacy. 
The positive findings regarding the amelioration of atten-
tion and vigilance, processing speed, verbal and visual 
learning and reasoning and problem solving reported in 
the present study are in concordance with several oth-
er studies that have utilized the CACR in patients with 
schizophrenia 11. Processing speed is related to the abil-
ity to carry out the activities of daily life, to the degree of 
independence achieved and to the ability to get a job and 
therefore seems to be the basis of the poor performance 
of other cognitive tests and the impairment of global func-
tioning  41. The advantage of CR for processing speed, 
attention/vigilance and verbal and visual learning in the 
present study suggests, however, that at least some ad-
ditional neurocognitive benefit may derive from the careful 
titration of task difficulty of cognitive exercises to ensure 
appropriate cognitive challenge, the rapid repetition of 
exacting exercises, and the frequency of reinforcement 
associated with achievement of intermediate and overall 
task goals characteristic of this condition. The hierarchi-
cal nature of the training program, starting with training in 
elementary attention skills and then graduating to consid-
erably more complex episodic and verbal memory tasks 
may also play a role in the advantage of this condition 42.
Thus, the finding of a no advantage of CACR on work-
Table I. Socio-demographic, clinical, cognitive and functioning characteristics of the sample at time zero.
Variables TAU Cogpack F/χ2 p
Age (years) 42.72±8.47 36.46±7.31 5.10 .03
Sex (male*) 10 3 1.09 .30
Single* 8 2 .28 .59
Employment* 21 10 1.22 .27
Scolarity (years) 11.08±3.82 13.23±3.47 2.88 .10
Age of onset 25.68±7.49 26.54±4.21 .15 .70
Duration of illness (years) 17.04±9.88 10.00±5.18 5.73 .02
PANSS-P 15.24±6.92 11.23±3.09 3.91 .06
PANSS-N 22.00±7.11 24.31±6.96 .95 .33
PANSS-G 36.08±9.98 36.54±10.63 .02 .90
PANSS total 72.96±17.95 72.85±16.69 .00 .98
CDSS 1.80±2.04 3.46±4.27 2.66 .11
Speed of processing 24.48±9.99 27.69±9.23 .93 .34
Social cognition 27.40±10.74 28.62±6.33 .14 .71
Working memory 29.64±11.16 31.38±9.94 .36 .55
Verbal learning 33.36±8.64 34.08±8.94 .06 .81
Reasoning/problem solving 32.28±4.71 34.00±9.46 .57 .46
Visual learning 35.92±14.06 36.92±17.34 .04 .85
Attention/vigilance 28.36±9.03 34.08±11.02 2.95 .09
SLOF total 179.12±17.35 175.00±18.70 .46 .50
Data are expressed as mean ± standard deviation. * data expressed as a number. Statistical analysis: One-way ANOVA for continuous variables; 
χ2 for categorical variables.
PANSS-P: Positive and Negative Syndrome Scale, positive symptomatology; PANSS-N: Positive and Negative Syndrome Scale, negative symp-
tomatology; PANSS-G: Positive and Negative Syndrome Scale, general symptomatology; PANSS total: Positive and Negative Syndrome Scale, 
total; CDSS: Calgary Depression Scale for Schizophrenia; SLOF total: Specific Level of Functioning, general functioning.
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Table II. Analysis of the variance of scores variations of clinical, cognitive and functioning evaluation scales in the two 
treatment groups.
TAU Cogpack ANOVA  within groups F (p)
ANOVA between 
groups F (p)
PANSS-P
T0
T1
15.24±6.92
12.00±3.91
11.23±3.09
11.77±4.30
3.38 (.04)* 1.72 (.20)
PANSS-N
T0
T1
22.00±7.11
21.52± 6.47
24.31±6.96
19.31±3.33
5.60 (.00)* .01 (.91)
PANSS-G
T0
T1
36.08±9.98
33.88±11.95
36.54±10.63
31.23±6.31
4.86 (.03)* .28 (.60)
CDSS
T0
T1
1.80±2.04
3.68±3.73
3.46±4.27
1.77±2.52
.94 (.39) .17 (.68)
Speed of processing
T0
T1 24.48±9.99
24.68±7.11
27.69±9.23
34.15±14.59
2.32 (.11) 6.28 (.02)*
Verbal learning
T0 
T1
33.36±8.64
31.84±6.01
34.08±8.94
47.62±9.86
12.39 (.00)* 11.55 (.00)*
Working memory 
T0
T1
29.24±10.76
29.64±11.16
31.38±9.94
35.62±11.13
1.05(.35) 1.87 (.18)
Reasoning and problem solving
T0
T1
32.28±4.71
30.08±3.90
34.00±9.46
39.23±8.17
1.94 (.15) 9.84 (.00)*
Visual learning
T0
T1
35.92±14.06
33.24±12.19
36.92±17.34
48.23±16.15
1.51 (.23) 5.20 (.03)*
Attention/vigilance
T0
T1
28.36±9.03
27.40±7.27
34.08±11.02
33.62±13.96
.19 (.83) 4.64 (.04)*
Social cognition
T0
T1
27.40±10.74
25.52±5.90
28.62±6.33
32.69±10.34
1.40 (.25) 6.72 (.01)*
SLOF phisical conditions
T0
T1 24.60±1.04
24.40±.91
24.85±.38
24.92±.28
.69 (.50) 2.47 (.12)
SLOF self-care
T0
T1
32.76±2.77
32.27±2.49
31.31±3.75
32.46±2.22
.29 (.75) .32 (.57)
SLOF Int_Rel
T0
T1
22.12±4.29
20.80±5.31
20.62±6.07
22.92±5.96
.78 (.46) .87 (.36)
SLOF Soc_Accet
T0
T1
34.54±.87
34.77±.44
31.44±4.12
32.80±3.86
2.58 (.08) 5.22 (.03)*
SLOF Activities
T0
T1
47.76±5.67
44.48±6.96
44.31±6.74
44.31±5.14
1.48 (.23) .12 (.73)
SLOF Work_skills
T0
T1
19.64±5.37
20.34±4.89
16.38±5.72
19.92±5.60
.54 (.59) .045 (.83)
SLOF totale
T0
T1
179.12±17.35
175.84±16.77
175.00±18.70
178.62±11.76
.59(.55) .14 (.71)
Data are expressed as an average (standard deviation). Statistical analysis: ANOVA with repeated measures. * Significant value: p≤0.05.
PANSS-P: Positive and Negative Syndrome Scale, positive symptomatology; PANSS-N: Positive and Negative Syndrome Scale, negative symp-
tomatology; PANSS-G: Positive and Negative Syndrome Scale, general psychopathology; CDSS: Calgary Depression Scale for Schizophrenia; 
SLOF physical conditions: Specific Level of Functioning, physical abilities; SLOF Self-care: Specific Level of Functioning, self-care skills; SLOF 
Int_Rel: Specific Level of Functioning, interpersonal relationships: SLOF Soc_Accet: Specific Level of Functioning, social acceptability; SLOF 
Activities: Specific Level of Functioning, daily activities; SLOF Work-skills: Specific Level of Functioning, work skills; SLOF total: Specific Level 
of Functioning, general functioning.
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ing memory (a skill related to holding information in mind 
and manipulating that information), but accompanying 
evidence of a commensurate advantage in the reason-
ing/executive-function and problem solving domain in the 
CACR group is paradoxical as several studies have shown 
a close link between more elementary working-memory 
functions and higher-level reasoning and problem-solving 
skills 43. Indeed, no effect was found in the domain of rea-
soning and problem solving when comparing computer-
ized cognitive training to a control group in the meta-anal-
ysis of Prikken and colleagues (2019). This might be not 
surprising, as problem solving is a complex skill which is 
of great importance in everyday functioning 44. Teaching 
strategies used by the therapist during and after CACR 
sessions in our study could explain our results. Indeed, 
the one-to-one interaction with a therapist who can ex-
plicitly encourage “bridging” strategies, as well as provide 
nonspecific support and motivational coaching form a 
meaningful components of the CACR therapy.
The same applies to social cognition: we found significant 
effect for this domain in the CACR group compared to the 
control active group. Social cognition is the set of mental 
functions that allow individuals of the same species to in-
teract with each other, is defined as the ability to under-
stand, predict and respond appropriately to the thoughts, 
feelings and behavior of others in social contexts differ-
ent and often unfamiliar 45 46. In literature, there are some 
studies that have tested the effects and possible improve-
ments in social cognition, after CACR. Almost all agree 
that when coupled with rehabilitative programs focused on 
emotional intelligence, the benefits on recognition of emo-
tions and the ability to interpret the feelings and behavior 
of others are more 47 48. The three studies included in the 
meta-analysis of Prikken and colleagues did not detect 
a connection between CACR treatment and an improve-
ment in emotional intelligence 11.
Moreover, the analysis regarding functional outcome re-
sulted in a very small effect, as CACR was effective in im-
proving only SLOF Social Acceptability subscale, in which 
are evaluated different aspects: the possible presence of 
verbal, physical abuse, physical aggression towards one-
self, reiteration of certain behaviors (steps, oscillations, 
etc.), whether the subject destroys goods, whether the 
patient shows fear, cries or appropriates the property of 
others without authorization. A treatment period of a maxi-
mum length of 6 months may have been too short to rate 
more functioning differences between treatment groups, 
as some changes in the real-world functioning may take 
a relatively long time before becoming apparent, such as 
one year or more.
Conflicting results are reported in literature. Small to mod-
erate, but only marginally significant effects on functional 
outcomes were found in the meta-analysis of Prikken et al. 
(2019), in contrast with other ones, that included also stud-
ies using strategy training, showing larger and significant 
effects 10 16 17.
This might suggest that CACR training alone might not be 
sufficient to improve daily functioning. Learning strategies 
might be a prerequisite for generalization of CACR treat-
ment effects, as improvement of NC does not translate into 
improved social functioning 49 50. It has been hypothesized 
that CR improves capacity to learn through increased ver-
bal memory or executive functioning, and in the absence 
of concerted learning opportunities, improved cognitive 
functioning does not automatically lead to improved psy-
chosocial functioning, as discussed in McGurk et al. 9 51. 
Indeed, it was then demonstrated that CR is more likely 
to influence functioning when patients are given the op-
portunity to train cognitive skills in the context of a social 
learning environment through transferring skills from labo-
ratory to real world and if it is combined with other psy-
chosocial rehabilitation programs 16 50. Our protocol study 
also focused on transferring learned abilities to the real 
world through 10-minutes discussion with the therapist at 
the end of each CACR session.
Moreover, the differences in literature could depend on 
the different scales administered to patients.
Finally, our results corroborate those of previous studies 
which showed a non-specific impact on symptoms in the 
CACR group 52-54 and are only partially consistent with evi-
dence from Prikken et al. (2019), who showed a significant 
improvement of positive symptoms after CACR relative to 
a control condition, whereas small to moderate, but only 
marginally significant effects on negative symptoms were 
found. No effect of CACR on general symptoms was de-
tected. 
This study presents limitations and strengths. As for the 
formers, a first limitation of this study is its relatively small 
sample size: further studies on larger populations would 
be necessary to investigate more closely the relationship 
between type of treatment and cognitive functions, func-
tioning in real life and symptomatology. Secondly, in this 
study only patients in stable phase of disease were in-
cluded: it remains unclear to what degree these findings 
would generalize to patients earlier or later in the course 
of their illness, in long-term inpatient or nursing home 
care, or who are in comorbidity with substances abuse. 
Third, there was no independent randomization. But NC 
and symptoms were assessed blind to group allocation 
which strengthens our results. However, as our study was 
not blinded and patients receiving the intervention were 
offered increased attention, clinical care, and individual-
ized contact on a frequent basis, this may have possibly 
influenced the positive cognitive outcomes in this group. 
Fourth, another factor that theoretically has the potential 
to influence whether CACR is found to be effective or not 
is choice of the control intervention. Although use of an 
active control may be desirable, it is important to ensure 
that the control task is sufficiently different from therapy to 
avoid it itself having positive beneficial effects on cogni-
tion  55. The control active group we employed engaged 
cognitive functions, not of a drill and practice type. It makes 
at most minimal demands on executive function, and while 
it does require memory, this is procedural memory, which 
is universally considered to be dissociable from episodic 
memory as trained in CACR 56. Also arguing against the 
possibility that our control intervention was therapeutic is 
the fact that we found significant differences at the end of 
the trial between the CACR and the active control group 
on some neuropsychological measures. Fifth, the fact that 
the study was conducted in an open unit, where patients 
had an opportunity to go out to the community might have 
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impacted the results, introducing uncontrolled variables, 
i.e., time spent in the community. Future studies could 
ensure that the active control task does not contain any 
form of cognitive training, although this could be extremely 
hard to accomplish. Sixth, the study could be viewed as 
lacking enough power to detect eventual differences be-
tween CACR and control group. This is a common prob-
lem in CACR trials, as detection of small effects requires 
large samples. Recruitment of large groups of patients is 
a great challenge, especially if it is conducted in a single 
unit. The duration of the study would substantially extend 
given that interventions take several weeks 57. Lastly, we 
did not evaluate the long-lasting effects of these treat-
ments after their discontinuation.
Some strengths of this study should be noted, including the 
well-matched baseline clinical, demographic, and cogni-
tive characteristics of the two groups; the strict inclusion 
criteria; the absence of comorbid conditions that may have 
biased the study outcome measures; the accurate evalua-
tion of cognitive functions, performed through the MCCB, 
and real-world functioning, evaluated through the Specific 
Level of Functioning Scale (SLOF), indicated as the best 
scale to estimate psychosocial functioning of schizophrenia 
patients among those included in the VALERO program. 
Lastly, diagnoses were based on structured clinical inter-
views and all patients were evaluated by trained raters.
In conclusion, if confirmed, our data suggest the impor-
tance of CACR aimed at implementing cognitive skills, so-
cial cognition and functioning in daily life in patients with 
schizophrenia.
Future studies are necessary to determine the durability 
of the improvements. While the effectiveness of the CACR 
has been demonstrated, further studies are needed to as-
sess the effects over time.
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